DEF: Regional Health Properties Sets 2025 Annual Meeting Agenda

Regional Health Properties, Inc. announces its 2025 Annual Meeting of Shareholders to vote on director elections, an amended incentive plan, executive compensation, and auditor ratification.

Summary

• The 2025 Annual Meeting of Shareholders for Regional Health Properties, Inc. will be held on December 30, 2025, at 10:00 a.m. local time in Atlanta, Georgia.
• Shareholders will vote on the election of seven director nominees, with four elected by common stock holders, one by Series B Preferred Stock holders, and two by Series D Preferred Stock holders.
• A key proposal is the approval of the Regional Health Properties, Inc. Amended and Restated 2023 Omnibus Incentive Compensation Plan, which would increase the total number of authorized shares for issuance from 225,000 to 775,000.
• Advisory votes will be conducted on executive compensation (Say-on-Pay) and the preferred frequency for future Say-on-Pay votes, with the Board recommending a three-year interval.
• The ratification of Cherry Bekaert, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2025, is also on the agenda.
• The company reported a net loss of $(3,218,000) for the fiscal year ended December 31, 2024, an improvement from $(3,888,000) in 2023 and $(6,867,000) in 2022.
• Total Shareholder Return (TSR) for a $100 investment, assuming investment on December 31, 2021, was $34.59 by December 31, 2024, down from $44.99 in 2023 and $73.61 in 2022.
• As of November 14, 2025, there were 3,934,677 shares of common stock, 1,885,913 shares of Series B Preferred Stock, and 1,405,609 shares of Series D Preferred Stock outstanding.

Sentiment

Score: 4

Explanation: The filing is primarily administrative, detailing proposals for an annual meeting. While it highlights efforts to improve governance and talent retention through an incentive plan, the underlying financial performance (continued net losses and declining TSR) is negative. The resignation of the CAO also adds a slight negative tone. The merger is a significant event but its financial impact is not detailed here.

Positives

• The proposed Amended and Restated 2023 Omnibus Incentive Compensation Plan is designed to attract and retain highly qualified employees, consultants, and non-employee directors, promoting ownership and aligning interests with shareholders.
• The company's net loss has shown an improving trend, decreasing from $(6,867,000) in 2022 to $(3,218,000) in 2024.
• The Board has a robust corporate governance structure, including a Lead Independent Director and all standing Board committees composed entirely of independent directors (excluding the CEO), enhancing oversight and independence.
• The recent merger with SunLink Health Systems, Inc. (effective August 14, 2025) has brought new directors with diverse experience to the Board.

Negatives

• The company continues to report significant net losses, with $(3,218,000) for the fiscal year ended December 31, 2024.
• Total Shareholder Return (TSR) has declined substantially, with a $100 investment on December 31, 2021, being worth only $34.59 by December 31, 2024.
• Heather L. Pittard, the Chief Accounting Officer and principal accounting officer, resigned effective February 15, 2025, which could signal instability in key financial leadership.
• Executive compensation for Mr. Morrison included a $150,000 bonus in 2023 despite the company reporting a net loss of $(3,888,000) in the same year.

Risks

• Failure to approve the Amended and Restated 2023 Omnibus Incentive Compensation Plan could hinder the company's ability to use equity awards for recruitment and retention, potentially leading to the loss of key executives and employees to competitors, which would be disruptive and detrimental to strategic goals and shareholder value.
• The company's status as a Real Estate Investment Trust (REIT) is critical, and the incentive plan is structured to avoid impairing this status; any actions that jeopardize REIT compliance could have significant adverse financial and tax consequences.

Future Outlook

The company expects that the shares available under the Amended and Restated 2023 Omnibus Incentive Compensation Plan, if approved by shareholders, will be sufficient for currently-anticipated awards for the next three years. This plan is crucial for the company's continued ability to attract and retain top talent. The Board recommends holding future Say-on-Pay votes every three years to allow for long-term assessment of executive compensation effectiveness.

Management Comments

• "It is my pleasure to invite you to attend the 2025 Annual Meeting of Shareholders... We look forward to personally seeing as many of our shareholders as possible." Brent S. Morrison, CEO, President, Corporate Secretary and Chairman of the Board of Directors
• "Your vote on the business to be considered at the Annual Meeting is important, regardless of the number of shares you own." Brent S. Morrison, CEO, President, Corporate Secretary and Chairman of the Board of Directors
• "The Board believes that it is prudent and in the best interest of the Company for shareholders to approve this proposal, to ensure that the Company retains the ability to use equity awards as a means of recruitment, retention and compensation for top talent." Board of Directors
• "The Board believes its leadership structure promotes strategy development and is optimal for effective corporate governance." Board of Directors

Industry Context

Regional Health Properties, Inc. operates as a real estate investment trust (REIT) in the healthcare sector. The recent merger with SunLink Health Systems, Inc. (effective August 14, 2025) indicates a strategic move towards consolidation or expansion within the healthcare industry. The emphasis on incentive compensation plans and corporate governance aligns with broader industry trends to attract and retain skilled management and ensure robust oversight in a competitive and regulated environment.

Comparison to Industry Standards

• The filing does not provide specific comparable companies, projects, or results to global benchmarks for direct assessment.
• The company's compliance with OTCQB Venture Market rules for independent directors and audit committees indicates adherence to basic listing standards for smaller public companies, but does not offer a comparison to larger, more established REITs or healthcare companies.

Management Changes

Corporate Governance

Related Party Transactions

• Steven L. Martin is affiliated with holders of the Company's Series B Preferred Stock and was nominated as a director by certain of these holders.
• Steven J. Baileys and Gene E. Burleson are affiliated with holders of the Company's Series D Preferred Stock and were nominated as directors in connection with the terms of this stock.
• Brent S. Morrison owns $120,000 aggregate principal amount of City of Springfield Ohio, First Mortgage Revenue Bonds (Eaglewood Property Holdings, LLC Project) Series 2012A through ZCM Opportunities Fund, LP, which are secured by the Eaglewood Village facility.
• All related party transactions were approved by the independent members of the Board without input from the related party, and the Board believes they were necessary and on terms no less favorable than could be obtained from independent third parties.

Stakeholder Impact

• **Shareholders (Common, Series B, Series D Preferred):** Directly impacted by the election of directors, approval of the incentive compensation plan (potential dilution vs. talent retention), and advisory votes on executive compensation and Say-on-Pay frequency. The declining TSR is a concern for all shareholders.
• **Employees & Executives:** The proposed Amended and Restated 2023 Omnibus Incentive Compensation Plan is designed to attract, retain, and motivate employees and executives through equity awards, linking pay to performance and fostering proprietary interest.
• **Customers & Suppliers:** No direct impact mentioned in this filing, which focuses on corporate governance and compensation.
• **Creditors:** Mr. Morrison's ownership of bonds secured by the Eaglewood Village facility indicates a related party creditor relationship, which was approved by independent directors.

Next Steps

• Shareholders will vote on the election of directors, approval of the Amended and Restated 2023 Omnibus Incentive Compensation Plan, advisory executive compensation, frequency of Say-on-Pay votes, and auditor ratification at the Annual Meeting on December 30, 2025.
• The company will implement the Amended and Restated 2023 Omnibus Incentive Compensation Plan if approved by shareholders.
• The Board will consider the results of the advisory vote on the frequency of Say-on-Pay in determining future voting intervals.
• Shareholders may submit proposals for inclusion in the 2026 proxy statement by a reasonable time before printing, adhering to Rule 14a-8 under the Exchange Act.

Key Dates

Recommendation

This filing is a proxy statement, primarily focused on administrative matters such as director elections, executive compensation, and an incentive plan. While it reveals continued net losses and a declining Total Shareholder Return, it does not contain new operational or financial results that would significantly alter the company's valuation in the short term. The proposed incentive plan is a standard corporate governance item aimed at talent retention, which is generally positive but also implies potential dilution. The merger with SunLink has already closed, and its impact is not fully detailed here. Given the lack of new, material financial or operational news, a 'hold' recommendation is appropriate as investors await future financial reports for more substantive insights into the company's performance post-merger and the effectiveness of its strategic initiatives.

Keywords

Regional Health Properties, RHE, SEC Filing, Proxy Statement, Annual Meeting, Director Election, Executive Compensation, Incentive Plan, Omnibus Incentive Compensation Plan, Corporate Governance, REIT, Healthcare Real Estate, Shareholder Vote, Audit Firm Ratification, Net Loss, Total Shareholder Return, SunLink Health Systems Merger